Dialysis Cartridge Recalled Due to Leakage

Shannon Weidemann
Contributor
Posted by Shannon WeidemannAugust 29, 2007 3:10 PM

Dialysis cartridges used in the NxStage's System One portable dialysis machine have been recalled due to potential dialysate leaks. The dialysis machines are used in 265 clinics around the country.

After discussing the leakage issue with the U.S. Food and Drug Administration, NxStage said in the SEC filing that it decided on August 24 to physically recall the affected lots of cartridge inventory being used by customers and patients, who would receive replacement cartridges at no charge. In addition, NxStage told patient and customers to destroy all affected cartridges.

The recall may cost the company $2.5 Million to replace all of the faulty cartridges. They may have a short term delay in getting new cartridges to clinics.


0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard New York City

InjuryBoard New York City RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board New York City is brought to you by Napoli Bern Ripka, LLP

Legal Assistance Center

More Info
Napoli Bern Ripka, LLP 866-735-1102 Ext. 300 www.nbrlawfirm.com
google
Personal Injury Lawyers Serving: New York City, Manhattan, Bronx, Brooklyn, Long Island, Nassau, Queens, Staten Island, Suffolk, Yonkers
350 5th AvenueSuite 7413, New York, New York 10118 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address